1,885
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Preparation and characterization of PLGA-β-CD polymeric nanoparticles containing methotrexate and evaluation of their effects on T47D cell line

, , , , , , & show all
Pages 432-440 | Received 15 Dec 2015, Accepted 27 Feb 2016, Published online: 22 Mar 2016

References

  • Abbasi E, Akbarzadeh A, Kouhi M, Milani M. 2015. Graphene: synthesis, bio-applications, and properties. Artif Cells Nanomed Biotechnol. 44:150–156.
  • Ahmadi-Aghkand F, Gholizadeh-Ghaleh Aziz S, Panahi Y, Daraee H, Gorjikhah F, Gholizadeh-Ghaleh Aziz S, Hsanzadeh A, Akbarzadeh A. 2015. Recent prospective of nanofiber scaffolds fabrication approaches for skin regeneration. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1111232.
  • Akbarzadeh A, Mikaeili H, Zarghami N, Mohammad R, Barkhordari A, Davaran S. 2012a. Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine. 7:511–526.
  • Akbarzadeh A, Rezaei-Sadabady R, Davaran S, Joo SW, Zarghami N, Hanifehpour Y, et al. 2013. Liposome: classification, preparation, and applications. Nanoscale Res Lett. 8:102.
  • Akbarzadeh A, Samiei M, Davaran S. 2012b. Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine. Nanoscale Res Lett. 7:1–13.
  • Akbarzadeh A, Samiei M, Joo SW, Anzaby M, Hanifehpour Y, Nasrabadi HT, Davaran S. 2012c. Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line. J Nanobiotechnology. 10:46.
  • Akbarzadeh A, Zarghami N, Mikaeili H, Asgari D, Goganian AM, Khiabani HK, Samiei M, Davaran S. 2012d. Synthesis, characterization, and in vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled delivery of doxorubicin. Nanotechnol Sci Appl. 5:13–25.
  • Alimohammadi YH, Joo SW. 2014. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac J Cancer Prev. 15:517–535.
  • Asin L, Ibarra MR, Tres A, Goya GF. 2012. Controlled cell death by magnetic hyperthermia: effects of exposure time, field amplitude, and nanoparticle concentration. Pharm Res. 29:1319–1327.
  • Babu A, Templeton AK, Munshi A, Ramesh R. 2013. Nanoparticle-based drug delivery for therapy of lung cancer: progress and challenges. J Nanomaterials. 2013:863951.
  • Barbosa JA, Zoppi A, Quevedo MA, de Melo PN, de Medeiros AS, Streck L, et al. 2014. Triethanolamine stabilization of methotrexate-β-cyclodextrin interactions in ternary complexes. Int J Mol Sci. 15:17077–17099.
  • Baviskar DT, Amritkar AS, Chaudhari HS, Jain DK. 2012. Modulation of drug release from nanocarriers loaded with a poorly water soluble drug (flurbiprofen) comprising natural waxes. Pharmazie. 67:701–705.
  • Brannon-Peppas L, Blanchette JO. 2012. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 64:206–212.
  • Cámara CI, Monzón LMA, Coey JMD, Yudi LM. 2014. Assembly of magnetic nanoparticles at liquid/liquid interface. Catalytic effect on ion transfer process. J Chem Phys. 143:77–83.
  • Cervadoro A, Giverso C, Pande R, Sarangi S, Preziosi L, Wosik J, Brazdeikis A, Decuzzi P. 2013. Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles. PLoS one. 8:e57332.
  • Chung JH, Kim YK, Kim KH, Kwon TY, Vaezmomeni SZ, Samiei M, et al. 2015. Synthesis, characterization, biocompatibility of hydroxyapatite–natural polymers nanocomposites for dentistry applications. Artif Cells Nanomed Biotechnol. 44:277–284.
  • Daraee H, Eatemadi A, Abbasi E, Fekri Aval S, Kouhi M, Akbarzadeh A. 2016a. Application of gold nanoparticles in biomedical and drug delivery. Artif Cells Nanomed Biotechnol. 44:410–422.
  • Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A. 2016b. Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol. 44:381–391.
  • Daraee H, Pourhassanmoghadam M, Akbarzadeh A, Zarghami N, Rahmati-Yamchi M. 2015. Gold nanoparticle–oligonucleotide conjugate to detect the sequence of lung cancer biomarker. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1031905.
  • Davaran S, Akbarzadeh A, Nejati-Koshki K, Alimohammadi S, Ghamari MF, Soghrati MM, Rezaei A, Khandaghi AA. 2013. In vitro studies of NIPAAM-MAA-VP copolymer-coated magnetic nanoparticles for controlled anticancer drug release*. JEAS. 3:108–115.
  • Davaran S, Rezaei A, Alimohammadi S, Khandaghi AA, Nejati-Koshki K, Nasrabadi HT, Akbarzadeh A. 2014. Synthesis and physicochemical characterization of biodegradable star-shaped poly lactide-co-glycolide-β-cyclodextrin copolymer nanoparticles containing albumin. J Adv Nanoparticles. 3:14–22.
  • Ding W, Wang F, Zhang J, Guo Y, Ju S, Wang H. 2013. A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern. Nanotechnology. 24:375101.
  • Disch S, Wetterskog E, Hermann RP, Wiedenmann A, Vainio U, Salazar-Alvarez G, Bergström L, Brückel Th. 2012. Quantitative spatial magnetization distribution in iron oxide nanocubes and nanospheres by polarized small-angle neutron scattering. New J Phys. 14:013025.
  • Eatemadi A, Darabi M, Afraidooni L, Zarghami N, Daraee H, Eskandari L, Mellatyar H, Akbarzadeh A. 2015. Comparison, synthesis and evaluation of anticancer drug-loaded polymeric nanoparticles on breast cancer cell lines. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1008510.
  • Eatemadi A, Daraee H, Karimkhanloo H, Kouhi M, Zarghami N, Akbarzadeh A, et al. 2014. Carbon nanotubes: properties, synthesis, purification, and medical applications. Nanoscale Res Lett. 9:1–13.
  • Eatemadi A, Daraee H, Zarghami N, Melat Yar H, Akbarzadeh A. 2016. Nanofiber: synthesis and biomedical applications. Artif Cells Nanomed Biotechnol. 44:111–121.
  • Fakhravar Z, Ebrahimnejad P, Daraee H, Akbarzadeh A. 2015. Nanoliposomes: synthesis methods and applications in cosmetics. J Cosmet Laser Ther. 12:1–31.
  • Freitas S, Merkle HP, Gander B. 2005. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Control Release. 102:313–332.
  • Gholizadeh-Ghaleh Aziz S, Gholizadeh-Ghaleh aziz S, Akbarzadeh A. 2015. The potential of nanofibers in tissue engineering and stem cell therapy. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1029627.
  • Ghosh P, Han G, De M, Kim CK, Rotello VM. 2008. Gold nanoparticles in delivery applications. Adv Drug Deliv Rev. 60:1307–1315.
  • Gudoshnikov SA, Liubimov B, Sitnov Y, Skomarovsky V, Usov N. 2013. AC magnetic technique to measure specific absorption rate of magnetic nanoparticles. J Supercond Nov Magn. 26:857–860.
  • Gudoshnikov SA, Ya Liubimov B, Usov NA. 2012. “Hysteresis losses in a dense superparamagnetic nanoparticle assembly.” AIP Advances. 2:012143.
  • Hadjipanayis Costas G, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H. 2010. EGFRvIII antibody–conjugated iron oxide nanoparticles for magnetic resonance imaging–guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer Res. 70:6303–6312.
  • Herizchi R, Abbasi E, Milani M, Akbarzadeh A. 2016. Current methods for synthesis of gold nanoparticles. Artif Cells Nanomed Biotechnol. 44:596–602.
  • Jiang L, Li X, Liu L, Zhang Q. 2013. Thiolated chitosan-modified PLA-PCL-TPGS nanoparticles for oral chemotherapy of lung cancer. Nanoscale Res Lett. 8:66.
  • Kafshdooz L, Kafshdooz T, Razban Z, Akbarzadeh A. 2015a. The application of gold nanoparticles as a promising therapeutic approach in breast and ovarian cancer. Artif Cells Nanomed Biotechnol. [Epub ahead of print]. doi: 10.3109/21691401.2015.1029625.
  • Kafshdooz T, Kafshdooz L, Akbarzadeh A, Hanifehpour Y, Joo SW. 2015b. Applications of nanoparticle systems in gene delivery and gene therapy. Artif Cells Nanomed Biotechnol. 44:581–587.
  • Kimura S, Egashira K, Chen L, Nakano K, Iwata E, Miyagawa M, et al. 2009. Nanoparticle-mediated delivery of nuclear factor κB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension. 53:877–883.
  • Kong M, Li X, Wang C, Ding C, Dong A, Duan Q, Shen Z. 2012. Tissue distribution and cancer growth inhibition of magnetic lipoplex-delivered type 1 insulin-like growth factor receptor shRNA in nude mice. Acta Biochim Biophys Sin (Shanghai). 44:591–596.
  • Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, et al. 2005. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res. 65:5317–5324.
  • Landi GT. 2013. Simple models for the heating curve in magnetic hyperthermia experiments. J Magn Magn Mater. 326:14–21.
  • Lü JM, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, Chen C. 2009. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert Rev Mol Diagn. 9:325–341.
  • Mahapatro A, Singh DK. 2011. Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnology. 9:55.
  • Majidi S, Zeinali Sehrig F, Farkhani SM, Soleymani Goloujeh M, Akbarzadeh A. 2015. Current methods for synthesis of magnetic nanoparticles. Artif Cells Nanomed Biotechnol. 44:722–734.
  • Martinez-Boubeta C, Simeonidis K, Makridis A, Angelakeris M, Iglesias O, Guardia P, et al. 2013. Learning from nature to improve the heat generation of iron-oxide nanoparticles for magnetic hyperthermia applications. Sci Rep. 3:1652.
  • Mellatyar H, Akbarzadeh A, Rahmati M, Ghalhar MG, Etemadi A, Nejati-Koshki K, Zarghami N, Barkhordari A. 2014. Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer. Asian Pac J Cancer Prev. 15:8693–8698.
  • Milani M, Sharifi Y, Rahmati-Yamchi M, Somi MH, Akbarzadeh A. 2015. Immunology and vaccines and nanovaccines for Helicobacter pylori infection. Expert Rev Vaccines. 14:833–840.
  • Mollazade M, Nejati-Koshki K, Akbarzadeh A, Hanifehpour Y, Zarghami N, Joo S. 2013. PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase. Asian Pac J Cancer Prev. 14:6925–6928.
  • Mulens V, María del Puerto M, Barber DF. 2013. Development of magnetic nanoparticles for cancer gene therapy: a comprehensive review. ISRN Nanomaterials. 2013:646284.
  • Munaweera I, Shi Y, Koneru B, Saez R, Aliev A, Di Pasqua AJ, Balkus KJ Jr. 2015. Chemoradiotherapeutic magnetic nanoparticles for targeted treatment of nonsmall cell lung cancer. Mol Pharm. 12:3588–3596.
  • Nejati-Koshki K, Akbarzadeh A, Pourhasan-Moghadam M, Joo S. 2013. Inhibition of leptin and leptin receptor gene expression by silibinin-curcumin combination. Asian Pac J Cancer Prev. 14:6595–6599.
  • Obaidat IM, Issa B, Haik Y. 2015. Magnetic properties of magnetic nanoparticles for efficient hyperthermia. Nanomaterials. 5:63–89.
  • Pourhassan-Moghaddam M, Rahmati-Yamchi M, Akbarzadeh A, Daraee H, Nejati-Koshki K, Hanifehpour Y, Joo SW. 2013. Protein detection through different platforms of immuno-loop-mediated isothermal amplification. Nanoscale Res Lett. 8:1–11.
  • Rivas J, Bañobre-López M, Piñeiro-Redondo Y, Rivas B, López-Quintela MA. 2012. Magnetic nanoparticles for application in cancer therapy. J Magn Magn Mater. 324:3499–3502.
  • Sadhukha T, Wiedmann TS, Panyam J. 2013. Inhalable magnetic nanoparticles for targeted hyperthermia in lung cancer therapy. Biomaterials. 34:5163–5171.
  • Seidi K, Eatemadi A, Mansoori B, Jahanban-Esfahlan R, Farajzadeh D. 2014. Nanomagnet-based detoxifying machine: an alternative/complementary approach in HIV therapy. J AIDS Clin Res. 5:304. doi:10.4172/2155-6113.1000304.
  • Sukumar UK, Bhushan B, Dubey P, Matai I, Sachdev A, Packirisamy G. 2013. Emerging applications of nanoparticles for lung cancer diagnosis and therapy. Int Nano Lett. 3:1–17.
  • Thakor AS, Gambhir SS. 2013. Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J Clin. 63:395–418.
  • Tsuda H. 2010. Risk assessment studies of nanomaterials in Japan and other countries. Asian Pac J Cancer Prev. 11:13–14.
  • Xu T, Zhang N, Nichols HL, Shi D, Wen X. 2007. Modification of nanostructured materials for biomedical applications. Mater Sci Eng C. 27:579–594.
  • Zhang Z, van Duijneveldt JS. 2006. Experimental phase diagram of a model colloid-polymer mixture in the protein limit. Langmuir. 22:63–66.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.